View by Specialty

Trending

PC0924Houry_Graphic_01_WEB
September 11, 2024
4 min read
Save

CDC data reveal three social drivers that influence suicide risk

Gout News

SPONSORED CONTENT
Save
SPONSORED CONTENT
April 03, 2023
2 min read
Save

Venous thromboembolism risk increases within 30 days after gout flare

Venous thromboembolism risk increases within 30 days after gout flare

Patients with gout demonstrate an increased risk for venous thromboembolism during the 30 days following a flare consultation or hospitalization, according to data published in Arthritis & Rheumatology.

SPONSORED CONTENT
March 16, 2023
2 min read
Save

Family history paired with obesity or heavy alcohol use ‘markedly’ increase gout risk

Family history paired with obesity or heavy alcohol use ‘markedly’ increase gout risk

Individuals with a family history of gout and who are either obese or heavy alcohol consumers demonstrate a “markedly increased risk” for gout, according to data published in Arthritis Care & Research.

Trending

PC0924Houry_Graphic_01_WEB
September 11, 2024
4 min read
Save

CDC data reveal three social drivers that influence suicide risk

SPONSORED CONTENT
December 23, 2022
3 min read
Save

‘Trying not to overdo it’: What to tell patients about gout flares and holiday feasts

‘Trying not to overdo it’: What to tell patients about gout flares and holiday feasts

The holidays for many people represent a time of indulgence in food and drink, but for patients with gout, these feasts can be veritable minefields that can trigger painful flares.

SPONSORED CONTENT
December 21, 2022
2 min read
Save

Methotrexate plus pegloticase superior to pegloticase alone in gout

Methotrexate plus pegloticase superior to pegloticase alone in gout

Adding methotrexate to pegloticase increased treatment response, compared with pegloticase alone, in patients with uncontrolled gout, according to data published in Arthritis & Rheumatology.

SPONSORED CONTENT
December 20, 2022
2 min read
Save

Patients with gout may be at higher risk for severe COVID-19 even after vaccination

Patients with gout may be at higher risk for severe COVID-19 even after vaccination

Patients with gout, and especially women, may be at higher risk for SARS-CoV-2 infection and severe outcomes regardless of vaccination status, according to data published in Arthritis & Rheumatology.

SPONSORED CONTENT
December 03, 2022
1 min read
Save

Large genome-wide study finds ‘dozens’ of new causal genes, pathways in gout

Large genome-wide study finds ‘dozens’ of new causal genes, pathways in gout

PHILADELPHIA — Researchers have identified “dozens” of new causal genes and pathways responsible for disease activity in patients with gout, according to a presenter at ACR Convergence 2022.

SPONSORED CONTENT
November 11, 2022
4 min watch
Save

VIDEO: Pegloticase, methotrexate treats uncontrolled gout without compromising kidney

VIDEO: Pegloticase, methotrexate treats uncontrolled gout without compromising kidney

ORLANDO — In this video from ASN Kidney Week, Abdul A. Abdellatif, MD, discusses the efficacy of pegloticase treatment in conjunction with methotrexate for patients with uncontrolled gout.

SPONSORED CONTENT
November 09, 2022
1 min read
Save

FDA issues emergency use authorization for anakinra to treat COVID-19

FDA issues emergency use authorization for anakinra to treat COVID-19

The FDA has issued an emergency use authorization for anakinra injection in the treatment of COVID-19 among hospitalized adults with pneumonia requiring supplemental oxygen.

SPONSORED CONTENT
October 12, 2022
2 min read
Save

Sarcopenia, weight loss more common in patients with lower serum urate

Sarcopenia, weight loss more common in patients with lower serum urate

Sarcopenia and weight loss occur more frequently in patients with lower concentrations of serum urate, according to data published in Arthritis & Rheumatology.

SPONSORED CONTENT
August 27, 2022
2 min read
Save

Allopurinol fails to improve outcomes in ischemic heart disease

Allopurinol fails to improve outcomes in ischemic heart disease

In patients with ischemic heart disease older than 60 years, the uric acid-lowering drug allopurinol did not improve CV outcomes, according to results of the ALL-HEART trial presented at the European Society of Cardiology Congress.

View more
Healio Minute Subscribe to Healio Minute emails You're now subscribed to Healio Minute Emails
Healio Minute Subscribe to Healio Minute emails You're now subscribed to Healio Minute Emails